![Wei Zhang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 224 $ au 31/03/2026
Wei Zhang currently works at CASI Pharmaceuticals, Inc., as Senior Vice President from 2024.
Dr. Zhang also formerly worked at Sandoz (China) Pharmaceutical Co., Ltd., as Chief Executive Officer from 2011 to 2016, CASI Pharmaceuticals, Inc., as President & Chief Financial Officer from 2019 to 2020, Casi Beijing Pharmaceuticals Co. Ltd., as President from 2018 to 2019, and Ruiibo (Suzhou) Pharmaceutical Co., Ltd., as VP, Head-Public Affairs & Corporate Responsibility.
Dr. Zhang received his Masters Business Admin degree from the University of California, Los Angeles, undergraduate degree and graduate degree from the University of Science & Technology of China, and doctorate degree from the University of Utah.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2026 | 2 015 ( 0,01% ) | 224 $ | 31/03/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12/09/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Casi Beijing Pharmaceuticals Co. Ltd.
 Casi Beijing Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | President | 01/09/2019 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Directeur Général | 01/01/2016 |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
 Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Directeur Financier/CFO | 16/12/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 8 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Health Technology |
Casi Beijing Pharmaceuticals Co. Ltd.
Casi Beijing Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
CASI Pharmaceuticals, Inc.
 CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
